Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab.

Huwart A, Garrigues F, Jousse-Joulin S, Marhadour T, Guellec D, Cornec D, Gouillou M, Saraux A, Devauchelle-Pensec V.

Arthritis Res Ther. 2018 Jan 25;20(1):11. doi: 10.1186/s13075-017-1499-2.

2.

Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren's syndrome.

Le Goff M, Cornec D, Jousse-Joulin S, Guellec D, Costa S, Marhadour T, Le Berre R, Genestet S, Cochener B, Boisrame-Gastrin S, Renaudineau Y, Pers JO, Saraux A, Devauchelle-Pensec V.

Arthritis Res Ther. 2017 Dec 6;19(1):269. doi: 10.1186/s13075-017-1475-x.

3.

Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire.

Gossec L, Chauvin P, Saraux A, Hudry C, Cukierman G, de Chalus T, Dreuillet C, Saulot V, Tong S, Russo-Marie F, Joubert JM, Berenbaum F.

Ann Rheum Dis. 2018 Feb;77(2):258-263. doi: 10.1136/annrheumdis-2017-212000. Epub 2017 Nov 4.

4.

Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates.

Harvard S, Guh D, Bansback N, Richette P, Saraux A, Fautrel B, Anis A.

Cost Eff Resour Alloc. 2017 Sep 7;15:20. doi: 10.1186/s12962-017-0081-8. eCollection 2017.

5.

Salivary gland ultrasound abnormalities in primary Sjögren's syndrome: consensual US-SG core items definition and reliability.

Jousse-Joulin S, Nowak E, Cornec D, Brown J, Carr A, Carotti M, Fisher B, Fradin J, Hocevar A, Jonsson MV, Luciano N, Milic V, Rout J, Theander E, Stel A, Bootsma H, Vissink A, Baldini C, Baer A, Ng WF, Bowman S, Alavi Z, Saraux A, Devauchelle-Pensec V.

RMD Open. 2017 Jun 9;3(1):e000364. doi: 10.1136/rmdopen-2016-000364. eCollection 2017.

6.

Multireader assessment as an alternative to reference assessment to improve the detection of radiographic progression in a large longitudinal cohort of rheumatoid arthritis (ESPOIR).

Gandjbakhch F, Granger B, Freund R, Foltz V, Jousse-Joulin S, Devauchelle V, Afshar M, Albert JD, Bailly F, Constant E, Biale L, Milin M, Couderc M, Denarie D, Fradin A, Martaille V, Pierreisnard A, Poursac N, Saraux A, Fautrel B.

RMD Open. 2017 Jan 4;3(1):e000343. doi: 10.1136/rmdopen-2016-000343. eCollection 2017.

7.

Interleukin-6: a promising target for the treatment of polymyalgia rheumatica or giant cell arteritis?

Toussirot É, Régent A, Devauchelle-Pensec V, Saraux A, Puéchal X.

RMD Open. 2016 Aug 31;2(2):e000305. eCollection 2016. No abstract available.

8.

High-Grade Salivary-Gland Involvement, Assessed by Histology or Ultrasonography, Is Associated with a Poor Response to a Single Rituximab Course in Primary Sjögren's Syndrome: Data from the TEARS Randomized Trial.

Cornec D, Jousse-Joulin S, Costa S, Marhadour T, Marcorelles P, Berthelot JM, Hachulla E, Hatron PY, Goeb V, Vittecoq O, Nowak E, Pers JO, Devauchelle-Pensec V, Saraux A.

PLoS One. 2016 Sep 23;11(9):e0162787. doi: 10.1371/journal.pone.0162787. eCollection 2016.

9.

Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort data.

Granger B, Combe B, Le Loet X, Saraux A, Guillemin F, Fautrel B.

RMD Open. 2016 May 20;2(1):e000245. doi: 10.1136/rmdopen-2016-000245. eCollection 2016.

10.

Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort.

Carvajal Alegria G, Guellec D, Mariette X, Gottenberg JE, Dernis E, Dubost JJ, Trouvin AP, Hachulla E, Larroche C, Le Guern V, Cornec D, Devauchelle-Pensec V, Saraux A.

RMD Open. 2016 Apr 20;2(1):e000179. doi: 10.1136/rmdopen-2015-000179. eCollection 2016.

11.

Predictive value of tender joints compared to synovitis for structural damage in rheumatoid arthritis.

Cheung PP, Mari K, Devauchelle-Pensec V, Jousse-Joulin S, D'Agostino MA, Chalès G, Gaudin P, Mariette X, Saraux A, Dougados M.

RMD Open. 2016 Mar 17;2(1):e000205. doi: 10.1136/rmdopen-2015-000205. eCollection 2016.

12.

Platelet-rich plasma (PRP) treatment of sports-related severe acute hamstring injuries.

Guillodo Y, Madouas G, Simon T, Le Dauphin H, Saraux A.

Muscles Ligaments Tendons J. 2016 Feb 13;5(4):284-8. doi: 10.11138/mltj/2015.5.4.284. eCollection 2015 Oct-Dec.

13.

Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.

Devauchelle-Pensec V, Berthelot JM, Cornec D, Renaudineau Y, Marhadour T, Jousse-Joulin S, Querellou S, Garrigues F, De Bandt M, Gouillou M, Saraux A.

Ann Rheum Dis. 2016 Aug;75(8):1506-10. doi: 10.1136/annrheumdis-2015-208742. Epub 2016 Feb 29.

14.

Diagnostic impact of routine Lyme serology in recent-onset arthritis: results from the ESPOIR cohort.

Guellec D, Narbonne V, Cornec D, Marhadour T, Varache S, Dougados M, Daurès JP, Jousse-Joulin S, Devauchelle-Pensec V, Saraux A.

RMD Open. 2016 Jan 11;2(1):e000120. doi: 10.1136/rmdopen-2015-000120. eCollection 2016.

15.

Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort.

Seror R, Boudaoud S, Pavy S, Nocturne G, Schaeverbeke T, Saraux A, Chanson P, Gottenberg JE, Devauchelle-Pensec V, Tobón GJ, Mariette X, Miceli-Richard C.

Sci Rep. 2016 Jan 20;6:18421. doi: 10.1038/srep18421.

16.

B-cell and T-cell quantification in minor salivary glands in primary Sjögren's syndrome: development and validation of a pixel-based digital procedure.

Costa S, Schutz S, Cornec D, Uguen A, Quintin-Roué I, Lesourd A, Berthelot JM, Hachulla E, Hatron PY, Goeb V, Vittecoq O, Pers JO, Marcorelles P, Saraux A, Devauchelle-Pensec V.

Arthritis Res Ther. 2016 Jan 20;18:21. doi: 10.1186/s13075-016-0924-2.

17.

Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort.

Guellec D, Milin M, Cornec D, Tobon GJ, Marhadour T, Jousse-Joulin S, Chiocchia G, Vittecocq O, Devauchelle-Pensec V, Saraux A.

RMD Open. 2015 Jul 15;1(1):e000070. doi: 10.1136/rmdopen-2015-000070. eCollection 2015. Review.

18.

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.

Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dörner T, Ravaud P, Vitali C, Mariette X, Asmussen K, Jacobsen S, Bartoloni E, Gerli R, Bijlsma JW, Kruize AA, Bombardieri S, Bookman A, Kallenberg C, Meiners P, Brun JG, Jonsson R, Caporali R, Carsons S, De Vita S, Del Papa N, Devauchelle V, Saraux A, Fauchais AL, Sibilia J, Hachulla E, Illei G, Isenberg D, Jones A, Manoussakis M, Mandl T, Jacobsson L, Demoulins F, Montecucco C, Ng WF, Nishiyama S, Omdal R, Parke A, Praprotnik S, Tomsic M, Price E, Scofield H, L Sivils K, Smolen J, Laqué RS, Steinfeld S, Sutcliffe N, Sumida T, Valesini G, Valim V, Vivino FB, Vollenweider C.

RMD Open. 2015 Feb 20;1(1):e000022. doi: 10.1136/rmdopen-2014-000022. eCollection 2015. Review.

19.

Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?

Devauchelle-Pensec V, Gottenberg JE, Jousse-Joulin S, Berthelot JM, Perdriger A, Hachulla E, Hatron PY, Puechal X, Le Guern V, Sibilia J, Chiche L, Goeb V, Vittecoq O, Larroche C, Fauchais AL, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Dieudé P, Pers JO, Cornec D, Seror R, Mariette X, Nowak E, Saraux A.

PLoS One. 2015 Sep 14;10(9):e0133907. doi: 10.1371/journal.pone.0133907. eCollection 2015.

20.

Clinical predictors of time to return to competition following hamstring injuries.

Guillodo Y, Here-Dorignac C, Thoribé B, Madouas G, Dauty M, Tassery F, Saraux A.

Muscles Ligaments Tendons J. 2014 Nov 17;4(3):386-90. eCollection 2014 Jul.

Supplemental Content

Loading ...
Support Center